Espi Industries And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 2.25 Cr
- Company Age 47 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 10.79 Cr
- Revenue Growth 40.11%
- Profit Growth -1.80%
- Ebitda 20.81%
- Net Worth 19.29%
- Total Assets 24.47%
About Espi Industries And Chemicals
Espi Industries And Chemicals Pvt Ltd (EIACPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 March 1977 and has a history of 47 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.25 Cr.
The company has closed loans amounting to ₹10.79 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashwini Chadda, Arun Akinepally, Dhruv Chadda, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110TG1977PTC002142
- Company No.
002142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 1977
- Date of AGM
04 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Espi Industries And Chemicals Pvt Ltd offer?
Espi Industries And Chemicals Pvt Ltd offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Coir and Agro Products, Psyllium Husk, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Healthcare Products & Aids, Health Drinks, Antacid Suspensions, Pharmaceutical Tablets.
Who are the key members and board of directors at Espi Industries And Chemicals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashwini Chadda ![]() | Director | 08-Mar-1977 | Current |
Arun Akinepally ![]() | Director | 02-Dec-2006 | Current |
Dhruv Chadda ![]() | Whole-Time Director | 09-Nov-2015 | Current |
Akshita Chadda ![]() | Director | 14-Dec-2018 | Current |
Financial Performance of Espi Industries And Chemicals.
Espi Industries And Chemicals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 40.11% increase. The company also saw a slight decrease in profitability, with a 1.8% decrease in profit. The company's net worth Soared by an impressive increase of 19.29%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Espi Industries And Chemicals?
In 2023, Espi Industries And Chemicals had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹10.79 Cr
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 2.52 Cr
- Andhra Bank : 2.29 Cr
- Citibank : 2.15 Cr
- Citi Bank : 2.15 Cr
- Citibank N.A. : 1.00 Cr
- Others : 0.68 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Sep 2009 | Standard Chartered Bank | ₹2.52 Cr | Satisfied |
22 Nov 2007 | Citibank Na | ₹6.00 M | Satisfied |
27 Feb 2007 | Citibank N.A. | ₹7.50 M | Satisfied |
20 Jun 2006 | Citibank N.A. | ₹2.50 M | Satisfied |
31 Jan 2003 | Citibank | ₹2.15 Cr | Satisfied |
How Many Employees Work at Espi Industries And Chemicals?
Espi Industries And Chemicals has a workforce of 157 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Espi Industries And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Espi Industries And Chemicals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.